1. Home
  2. CYCN vs MOVE Comparison

CYCN vs MOVE Comparison

Compare CYCN & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cyclerion Therapeutics Inc.

CYCN

Cyclerion Therapeutics Inc.

N/A

Current Price

$1.55

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Logo Movano Inc.

MOVE

Movano Inc.

N/A

Current Price

$6.93

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CYCN
MOVE
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
6.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CYCN
MOVE
Price
$1.55
$6.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.4M
60.3K
Earning Date
03-03-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,855,000.00
$500,000.00
Revenue This Year
N/A
$1,460.71
Revenue Next Year
N/A
$96.77
P/E Ratio
N/A
N/A
Revenue Growth
1371.65
N/A
52 Week Low
$1.16
$4.67
52 Week High
$6.25
$58.76

Technical Indicators

Market Signals
Indicator
CYCN
MOVE
Relative Strength Index (RSI) 48.29 39.40
Support Level $1.58 $6.74
Resistance Level $2.00 $7.57
Average True Range (ATR) 0.18 0.68
MACD 0.02 -0.12
Stochastic Oscillator 32.14 1.08

Price Performance

Historical Comparison
CYCN
MOVE

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

Share on Social Networks: